Update on the diagnosis and treatment of alcoholic dilated cardiomyopathy

Authors

Keywords:

alcohol; alcoholic dilated cardiomyopathy; diagnosis; heart failure; treatment

Abstract

Introduction: Alcoholic dilated cardiomyopathy is a significant cause of non-ischemic heart failure resulting from chronic and excessive alcohol consumption. Although advances in elucidating its pathophysiological mechanisms are notable, early diagnosis and adequate treatment continue to present challenges in high-risk groups.

Objective: To update recent evidence on the pathophysiology, diagnosis, and treatment of alcoholic dilated cardiomyopathy.

Methods: A bibliographic review (2018-2025) was conducted according to PRISMA guidelines in PubMed, SciELO, and Cochrane. Out of 178 identified records, 27 studies (ESC guidelines, observational/prospective) were selected after title/abstract and full-text evaluation. Quality was assessed using GRADE/Newcastle-Ottawa scales. A narrative synthesis with critical analysis of reported statistical measures was performed.

Development: Alcoholic dilated cardiomyopathy results from direct myocardial damage induced by ethanol and oxidative stress, with nonspecific clinical manifestations. Its diagnosis requires a history of high alcohol consumption, echocardiographic evidence of ventricular dilatation and systolic dysfunction, and the exclusion of other cardiomyopathies. Abstinence is the cornerstone of treatment, complemented by standard pharmacotherapy for heart failure. A multidisciplinary management approach involving cardiology, addiction medicine, and psychosocial support is essential to optimize prognosis.

Conclusions: Alcoholic dilated cardiomyopathy requires a comprehensive approach that combines prevention, timely diagnosis, and standardized pharmacological treatment. Alcohol abstinence is crucial for the reversibility of ventricular dysfunction. The need for public policies to reduce its incidence and promote research into specific therapeutic targets is emphasized.

Downloads

Download data is not yet available.

References

1. Arbelo E, Protonotarios A, Gimeno JR, Arbustini E, Barriales-Villa R, Basso C, et al. Guidelines for the management of cardiomyopathies [Internet]. Eur Heart J. 2023; 44(37):3503-26. DOI: 10.1093/eurheartj/ehad194

2. Figueredo VM, Patel A. Detrimental effects of alcohol on the heart: hypertension and cardiomyopathy [Internet]. Rev Cardiovasc Med. 2023; 24(10): 292. DOI: 10.31083/j.rcm2410292

3. Georgescu OS, Martin L, Târtea GC, Rotaru-Zavaleanu AD, Dinescu SN, Vasile RC, et al. Alcohol Consumption and Cardiovascular Disease: A Narrative Review of Evolving Perspectives and Long-Term Implications [Internet]. Life. 2024; 14(9)1134. DOI: 10.3390/life14091134

4. Albakri A. Alcoholic cardiomyopathy: A review of literature on clinical status and meta-analysis of diagnostic and clinical management methods [Internet]. Clin Med Invest. 2018; 3(3): 2-14. DOI: 10.15761/CMI.1000165

5. Gróny A, Wójcik A, Chwiejczak J, Obrebski M, Koscian J, Mlynarska J, et al. Alcoholic Cardiomyopathy: a summary of current knowledge and possible future directions [Internet]. Journal of Education, Health and Sport. 2024; 69: 49619. DOI: 10.12775/JEHS.2024.69.49619

6. Domínguez F, Adler E, García-Pavía P. Alcoholic cardiomyopathy: an update [Internet]. Eur Heart J. 2024; 45(24):2294-305. DOI: 10.1093/eurheartj/ehae362

7. Vázquez-Ramírez EM, Mata-Vicente JF. Cardiomiopatía secundaria al consumo de alcohol [Internet]. Med Int Méx. 2016 [acceso: 11/01/2026]; 32(1):93-102. Disponible en: https://www.medigraphic.com/pdfs/medintmex/mim-2016/mim161l.pdf

8. Ely M, Hardy R, Longford NT, Wadsworth ME. Gender differences in the relationship between alcohol consumption and drink problems are largely accounted for by body water [Internet]. Alcohol Alcohol. 1999; 34(6):894-902. DOI: 10.1093/alcalc/34.6.894

9. Edavettal JM, Harris NR, Cohen SE, Paloczi J, Chandrasekar B, Gardner JD. Abstinence Restores Cardiac Function in Mice with Established Alcohol-Induced Cardiomyopathy [Internet]. Cells. 2023; 12(24):2783. DOI: 10.3390/cells12242783

10. Piano MR, Marcus GM, Aycock DM, Buckman J, Hwang CL, Larsson SC, et al. Alcohol use and cardiovascular disease: a scientific statement from the American Heart Association [Internet]. Circulation. 2025; 152(1):7-21. DOI: 10.1161/CIR.0000000000001341

11. Duarte-Segura N, Bonilla- Carrión R, Álvarez-Pineda MF, Evans-Meza R, Salvatierra- Durán R. Mortalidad por miocarditis alcohólica en América Latina, 2000-2019 [Internet]. Rev Hisp Cienc Salud. 2023; 9(2):69-84. DOI: 10.56239/rhcs.2023.92.639

12. Hamala P, Wierzbowska-Drabik K. Alcohol impact on the heart and cardiovascular system - hypertrophy, remodeling and strain impairment - contemporary state-of-the-art [Internet]. Rev Argent Cardiol. 2023; 91(1):70-78. DOI: 10.7775/rac.es.v91.i1.20592

13. Mouton AJ, El Hajj EC, Ninh VK, Siggins RW, Gardner JD. Inflammatory cardiac fibroblast phenotype underlies chronic alcohol- induced cardiac atrophy and dysfunction [Internet]. Life Sci.2020; 245: 117330. DOI: 10.1016/j.lfs.2020.117330

14. Orozco SP, Tobón J M, Gómez J P, Murgas CH, Rico M J, Calderón G, et al. Relación Y Características Epidemiológicas De La Cardiomiopatía Dilatada En Pacientes Con Cirrosis Hepática [Internet]. Ciencia Latina Revista Científica Multidisciplinar. 2024; 8(3): 6680-91. DOI: 10.37811/cl_rcm.v8i3.11865

15. Andersson C, Schou M, Gustafsson F, Torp-Pedersen C. Alcohol intake in patients with cardiomyopathy and heart failure: consensus and controversy [Internet]. Circ Heart Fail. 2022; 15(8):e009459. DOI: 10.1161/circheartfailure.121.009459

16. Askanas A, Udoshi M, Sadjadi SA. The heart in chronic alcoholism: a noninvasive study [Internet]. Am Heart J. 1980; 99(1):9-16. DOI: 10.1016/0002-8703(80)90309-9

17. Wang Y, Li G, Sun Y, Shan G, Xu R, Guo L. Left ventricular strain and rotation by 2-D speckle tracking echocardiography identify early alcoholic cardiomyopathy [Internet]. Ultrasound Med Biol. 2016; 42(8):1741–49. DOI: 10.1016/j.ultrasmedbio.2016.03.023

18. Porcari A, Baggio C, Fabris E, Merlo M, Bussani R, Perkan A, et al. Endomyocardial biopsy in the clinical context: current indications and challenging scenarios [Internet]. Heart Fail Rev. 2023; 28(1):123-35. DOI: 10.1007/s10741-022-10247-5

19. Falcao- Pires I, Ferreira AF, Trindade F, Bertrand L, Ciccarelli M, Visco V, et al. Mecanismos de remodelación miocárdica inversa y su significado clínico: Declaración del Grupo de Trabajo del Comité de la Función miocárdica [Internet]. European Journal of Heart Failure. 2024; 26(7): 1454-79. DOI: 10.1002/ejhf.3264

20. Brdgar A, Taha M, Awan A, Ogunti R, Garbin J, Hamad M, et al. The burden of substance use disorders among hospitalized patients with underlying cardiovascular or cerebrovascular disease in the United States [Internet]. J Vasc Surg. 2022; 10(6):462. DOI: 10.35248/2329-6925.22.10.462

21. Visseren FLJ, Mach F, Smulders YM, Carballo D, Koskinas KC, Bäck M, et al. ESC Scientific Document Group. ESC guidelines on cardiovascular disease prevention in clinical practice [Internet]. Eur Heart J. 2021; 42(34):3227-337. DOI: 10.1093/eurheartj/ehab484

22. Farokhnia M, Rentsch CT, Chuong V, McGinn MA, Elvig SK, Douglass EA, et al. Spironolactone as a potential new pharmacotherapy for alcohol use disorder: convergent evidence from rodent and human studies [Internet]. Molecular Psychiatry. 2022; 27(11): 4642–52. DOI: 10.1038/s41380-022-01736-y

23. Akbar RA, Lirani EA, Hasan MRD. Alcohol induced cardiomyopathy in non-alcoholic society: a case report of determining the etiology of dilated cardiomyopathy [Internet]. Sch J Med Case Rep. 2022; 10(4):348-56. DOI: 10.36347/sjmcr.2022.v10i04.020

24. Antonopoulos AS, Kasiakogias A, Kouroutzoglou A, Touloupaki M, Briasoulis A, Papatheodorou E, et al. Atrial fibrillation burden and management in cardiomyopathies: Current evidence and unmet needs [Internet]. Trends Cardiovasc Med. 2025; 35(5):284-93. DOI: 10.1016/j.tcm.2025.01.007

25. Haber PS, Riordan BC, Winter DT, Barrett L, Saunders J, Hides L, et al. New Australian guidelines for the treatment of alcohol problems: an overview of recommendations [Internet]. Med J Aust. 2021; 215(7):1-32. DOI: 10.5694/mja2.51254

26. Valdez P, Cortese S, Risso M, Puello H, Casariego E, Diaz Salazar L, et al. Alcohol y enfermedad cardiovascula [Internet]. Medicina (Buenos Aires). 2023 [acceso: 11/01/2026]; 83(Supl I):23-6. Disponible en: https://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S0025-76802023000100023&lng=es

27. Valente F, Pozzi M, Sebbag L, Baudry G. Left Ventricular Assist Device as a Bridge-to-Recovery Strategy in Alcoholic Cardiomyopathy: A Case Series [Internet]. Canadian Journal of Cardiology. 2025; 41(4):764–67. DOI: 10.1016/j.cjca.2024.08.278

Published

2026-05-21

How to Cite

1.
Payrol Pérez A, Hurtado Gascón LC, Acosta Queralta LG. Update on the diagnosis and treatment of alcoholic dilated cardiomyopathy. Rev. cuba. med. mil [Internet]. 2026 May 21 [cited 2026 May 26];55(2):e026077071. Available from: https://revmedmilitar.sld.cu/index.php/mil/article/view/77071